Rockville-based Neuralstem Inc. , developing stem cell treatments for brain and spinal cord injuries, will raise $19.65 million in a direct placement of common stock to institutional investors.
http://www.bizjournals.com/washington/news/2014/01/03/neuralstem-falls-on-stock-sale.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_36+%28Pharmaceutical+Industry+News%29
http://www.bizjournals.com/washington/news/2014/01/03/neuralstem-falls-on-stock-sale.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_36+%28Pharmaceutical+Industry+News%29
No comments:
Post a Comment